Civic Intelligence

Institute for Myeloma & Bone Cancer

EIN 46-0475333 • 501(c)3 • West Hollywood, CA

Profile

Form 990 part iii line 1 the institute for myeloma and bone cancer reserach is established for the following purposes: (i) to promote research in to the causes of myeloma, bone cancer, and related disorders, (ii)to support the development of therapies designed to treat and control myeloma, bone cancer, and related disorders, and (iii) to advance efforts directed at preventing the development of myeloma, bone cancer, and related disorders, including the treatment of persons having such diseases. The institute's two major activities will be (1) research related to the causes of myeloma and related disorders and (2) development of therapies to prevent and treat myeloma and related disorders.

9201 W Sunset Blvd Suite 300West Hollywood, CA 90069

www.imbcr.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

98th percentile

2.05x

Higher debt load relative to assets than 98% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

91st percentile

1.43x

Higher debt load relative to revenue than 91% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

82nd percentile

34%

Higher net margin than 82% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

40th percentile

$0

Higher top officer pay than 40% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Asset Growth

93rd percentile

77%

Faster asset growth than 93% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

89th percentile

86%

Faster revenue growth than 89% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets98th percentile

Assets

Up

$1,494,310

Up $649,673 (+77%) from 2023

Liabilities

Down

$3,056,453

Down $72,956 (-2.3%) from 2023

Net Assets

Up

-$1,562,143

Up $722,629 (+32%) from 2023

Operations
Liabilities / Revenue91st percentileNet Margin82nd percentile

Revenue

Up

$2,137,198

Up $991,187 (+86%) from 2023

Expenses

Up

$1,414,569

Up $121,473 (+9.4%) from 2023

Net Income

Up

$722,629

Up $869,714 (+591%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth93rd percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$4.0M$2.0M$0-$2.0M-$4.0MAssets 2010: $150,138Liabilities 2010: $196,185Net Assets 2010: -$46,0472010Assets 2011: $90,410Liabilities 2011: $469,353Net Assets 2011: -$378,9432011Assets 2012: $167,896Liabilities 2012: $517,153Net Assets 2012: -$349,2572012Assets 2013: $187,652Liabilities 2013: $570,246Net Assets 2013: -$382,5942013Assets 2014: $146,091Liabilities 2014: $783,235Net Assets 2014: -$637,1442014Assets 2015: $193,681Liabilities 2015: $797,034Net Assets 2015: -$603,3532015Assets 2016: $79,057Liabilities 2016: $829,504Net Assets 2016: -$750,4472016Assets 2017: $1,364,026Liabilities 2017: $914,064Net Assets 2017: $449,9622017Assets 2018: $412,082Liabilities 2018: $593,299Net Assets 2018: -$181,2172018Assets 2019: $133,838Liabilities 2019: $3,100,937Net Assets 2019: -$2,967,0992019Assets 2020: $706,051Liabilities 2020: $2,416,044Net Assets 2020: -$1,709,9932020Assets 2021: $278,054Liabilities 2021: $3,268,725Net Assets 2021: -$2,990,6712021Assets 2022: $660,470Liabilities 2022: $2,798,157Net Assets 2022: -$2,137,6872022Assets 2023: $844,637Liabilities 2023: $3,129,409Net Assets 2023: -$2,284,7722023Assets 2024: $1,494,310Liabilities 2024: $3,056,453Net Assets 2024: -$1,562,1432024

Highlighted filing

2024

Assets$1,494,310
Liabilities$3,056,453
Net Assets-$1,562,143
Open 2024 Filing

Operations Trend

Revenue Growth89th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$4.0M$2.0M$0-$2.0M-$4.0MExpenses 2010: $1,326,7802010Expenses 2011: $1,038,7732011Expenses 2012: $846,7792012Revenue 2013: $889,195Expenses 2013: $922,532Net Income 2013: -$33,3372013Revenue 2014: $1,213,638Expenses 2014: $1,468,188Net Income 2014: -$254,5502014Revenue 2015: $1,214,577Expenses 2015: $1,203,772Net Income 2015: $10,8052015Revenue 2016: $1,027,818Expenses 2016: $1,174,912Net Income 2016: -$147,0942016Revenue 2017: $1,662,275Expenses 2017: $887,526Net Income 2017: $774,7492017Revenue 2018: $1,023,481Expenses 2018: $1,654,660Net Income 2018: -$631,1792018Revenue 2019: $584,714Expenses 2019: $3,370,596Net Income 2019: -$2,785,8822019Revenue 2020: $2,661,444Expenses 2020: $1,404,338Net Income 2020: $1,257,1062020Revenue 2021: $1,373,547Expenses 2021: $2,654,225Net Income 2021: -$1,280,6782021Revenue 2022: $2,303,328Expenses 2022: $1,450,344Net Income 2022: $852,9842022Revenue 2023: $1,146,011Expenses 2023: $1,293,096Net Income 2023: -$147,0852023Revenue 2024: $2,137,198Expenses 2024: $1,414,569Net Income 2024: $722,6292024

Highlighted filing

2024

Revenue$2,137,198
Expenses$1,414,569
Net Income$722,629
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$1,494,310
Liabilities
$3,056,453
Net assets
-$1,562,143
Revenue
$2,137,198
Expenses
$1,414,569
Net income
$722,629
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$1.49$3.06$1.56$2.14$1.41$0.72
2023Detailed filing. Detailed filing data is available for this year.$0.84$3.13$2.28$1.15$1.29$0.15
2022Detailed filing. Detailed filing data is available for this year.$0.66$2.80$2.14$2.30$1.45$0.85
2021Detailed filing. Detailed filing data is available for this year.$0.28$3.27$2.99$1.37$2.65$1.28
2020Detailed filing. Detailed filing data is available for this year.$0.71$2.42$1.71$2.66$1.40$1.26
2019Detailed filing. Detailed filing data is available for this year.$0.13$3.10$2.97$0.58$3.37$2.79
2018Detailed filing. Detailed filing data is available for this year.$0.41$0.59$0.18$1.02$1.65$0.63
2017Detailed filing. Detailed filing data is available for this year.$1.36$0.91$0.45$1.66$0.89$0.77
2016Detailed filing. Detailed filing data is available for this year.$0.08$0.83$0.75$1.03$1.17$0.15
2015Detailed filing. Detailed filing data is available for this year.$0.19$0.80$0.60$1.21$1.20$0.01
2014Detailed filing. Detailed filing data is available for this year.$0.15$0.78$0.64$1.21$1.47$0.25
2013Detailed filing. Detailed filing data is available for this year.$0.19$0.57$0.38$0.89$0.92$0.03
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.17$0.52$0.35$0.85
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.09$0.47$0.38$1.04
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.15$0.20$0.05$1.33
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Feb 18, 2025
Return Version
2024v5.0
Gross Receipts
$2,137,198
Mission and Program Overview

Mission

Form 990 part iii line 1 the institute for myeloma and bone cancer reserach is established for the following purposes: (i) to promote research in to the causes of myeloma, bone cancer, and related disorders, (ii)to support the development of therapies designed to treat and control myeloma, bone cancer, and related disorders, and (iii) to advance efforts directed at preventing the development of myeloma, bone cancer, and related disorders, including the treatment of persons having such diseases. The institute's two major activities will be (1) research related to the causes of myeloma and related disorders and (2) development of therapies to prevent and treat myeloma and related disorders.

Form 990 part i line 1 the institute for myeloma and bone cancer reserach is established for the following purposes: (i) to promote research into the causes of myeloma, bone cancer, and related disorders, (ii)to support the development of therapies designed to treat and control myeloma, bone cancer, and related disorders, and (iii) to advance efforts directed at preventing the development of myeloma, bone cancer, and related disorders, including the treatment of persons having such diseases.

Balance Sheet Detail
LineBeginningEndChange
Assets
Loans From Officers Directors$2,750,073$2,878,184▲ $128,111
Inventories for Sale or Use$570,273$761,385▲ $191,112
Cash and Non-Interest-Bearing Accounts$175,418$234,919▲ $59,501
Pledges and Grants Receivable$5,000$157,708▲ $152,708
Prepaid Expenses and Deferred Charges$49,621$59,135▲ $9,514
Land, Buildings, and Equipment, Net$29,275$49,779▲ $20,504
Accounts Receivable$86$2,127▲ $2,041
Investments Other Securities$451$451→ $0
Rtn Earn Endowment Incm Other Fnds$-2,284,772$-1,562,143▲ $722,629
Total Assets$844,637$1,494,310▲ $649,673
Other Assets Total$14,513$228,806▲ $214,293
Liabilities
Other Liabilities$262,919$112,353▼ $150,566
Accounts Payable and Accrued Expenses$116,417$65,916▼ $50,501
Total Liabilities$3,129,409$3,056,453▼ $72,956
Net Assets / Fund Balance
Total Net Assets Fund Balance$-2,284,772$-1,562,143▲ $722,629
Total Liabilities and Net Assets / Fund Balance$844,637$1,494,310▲ $649,673

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$49,779$330,250$380,029
Other Assets Org$97,928--
Compensation and Service Providers
Top Officer Pay40th percentile

Board Members and Trustees

NameTitle
James R Berenson MdPresident an
Blake Morrison PharmdDirector
Cyndie DunlapDirector
Kelley NicholsDirector
Larry Stein EsqDirector
Merryl WerberDirector
Michael Schiff EsqDirector
Richard Gardiner MdDirector
Richard Kale EsqDirector
Roger FischerDirector
Shahrooz Eshaghian MdSecretary
Jessica YatacoTreasurer
Geo Hartley EsqVice Preside
Revenue and Support

Revenue Composition

Contributions and Grants
$1,547,145
Program Service Revenue
$121,761
Investment Income
$1
Other Revenue
$468,291
All Other Contributions
$1,527,240
Change in Net Assets
$722,629

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,137,198
Total Revenue per Audited Statements
$2,137,198
Total Revenue per Form 990
$2,137,198
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$1,054,058
Salaries, Compensation, and Employee Benefits$360,511
Total Fundraising Expense$80,096
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Management-$398,000-$398,000
Other Salaries and Wages-$312,133-$312,133
Occupancy-$138,658-$138,658
Interest$132,163--$132,163
All Other Expenses$6,684$59,002$782$66,468
Depreciation Depletion$48,223--$48,223
Advertising--$46,820$46,820
Insurance$35,507--$35,507
Payroll Taxes-$27,134-$27,134
Other Expenses$15,488-$1,966$17,454
Fees for Services Other-$13,130-$13,130
Fees for Services Accounting-$12,835-$12,835
Pension Plan Contributions-$12,035-$12,035
Conferences and Meetings$931$10,799-$11,730
Office Expenses-$10,442-$10,442
Other Employee Benefits-$9,209-$9,209
Fees for Services Legal-$2,972-$2,972
Total Functional Expenses$328,124$1,006,349$80,096$1,414,569

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$1,414,569
Total Expenses per Audited Statements$1,414,569
Total Expenses per Form 990$1,414,569
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Gross Income$83,299
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Events Income$103,204$83,299-$83,299
Total Events$103,204$83,299-$83,299
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$2,750,073$2,878,184▲ $128,111
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Leases & Notes Payable$70,954
Salary Payable$20,523
Short Term Notes$9,703
Accrued Expenses$7,273
Unearned Fundraising Revenue$3,900
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“The governing body meets and reviews the form 990 before it is filed.”

Form 990, Page 6, Part VI, Line 12C

“Officers, directors and trustees have to provide written statements annually regarding conflict of interest that may arise.”

Form 990, Page 6, Part VI, Line 15A

“Compensation has been reviewed and approved by the board for all leased employees”

Form 990, Page 6, Part VI, Line 15B

“Compensation has been reviewed and approved by the board for all leased employees”

Form 990, Page 6, Part VI, Line 19

“The organization makes its 990 available to the public upon request.”

Filing and Contact Details

Filer

Filer Name
Institute for Myeloma & Bone Cancer
EIN
46-0475333
Phone
3106231210
Address
9201 W SUNSET BLVD SUITE 300, WEST HOLLYWOOD, CA 90069

Signing Officer

Name
James R Berenson Md
Title
President and CMO
Phone
3106231211
Signed
2025-02-18
Discuss with paid preparer
Yes

Organization Details

Principal Officer
James R Berenson Md
Formed
2002
Legal Domicile
CA
Voting Board Members
12
Independent Board Members
12
Employees
5
Volunteers
5

Preparer

Firm
Dovid Einstein CPA Apc
Address
2029 CENTURY PARK EAST 4TH FLOOR, CENTURY CITY, CA 90067
Preparer
Dovid Einstein CPA
Phone
3104225219
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

“Form 990 part iii line 1 the institute for myeloma and bone cancer reserach is established for the following purposes: (i) to promote research in to the causes of myeloma, bone cancer, and related disorders, (ii)to support the development of therapies designed to treat and control myeloma, bone cancer, and related disorders, and (iii) to advance efforts directed at preventing the development of myeloma, bone cancer, and related disorders, including the treatment of persons having such diseases. The institute's two major activities will be (1) research related to the causes of myeloma and related disorders and (2) development of therapies to prevent and treat myeloma and related disorders.”

Form 990, Page 2, Part III, Line 3

“Imbcr started marketing and selling small amounts of blood and bone marrow samples.”

Form 990, Page 2, Part III, Line 4D

“Achieved advancements in the research and cure for myeloma. Research has helped cure or reduce the occurrence of myeloma in humans.”

Raw XML AppendixShowing 400 of 544 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0116417
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt065916
IRS990/AccountsReceivableGrp/BOYAmt086
IRS990/AccountsReceivableGrp/EOYAmt02127
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FORM 990 PART I LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH INTO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES.
IRS990/AdvertisingGrp/FundraisingAmt046820
IRS990/AdvertisingGrp/TotalAmt046820
IRS990/AllOtherContributionsAmt01527240
IRS990/AllOtherExpensesGrp/FundraisingAmt0782
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt059002
IRS990/AllOtherExpensesGrp/ProgramServicesAmt06684
IRS990/AllOtherExpensesGrp/TotalAmt066468
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/PersonNm0JAMES R BERENSON MD
IRS990/BooksInCareOfDetail/PhoneNum03106231210
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt09201 W SUNSET BLVD SUITE 300
IRS990/BooksInCareOfDetail/USAddress/CityNm0WEST HOLLYWOOD
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd090069
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0175418
IRS990/CashNonInterestBearingGrp/EOYAmt0234919
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0true
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt010799
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0931
IRS990/ConferencesMeetingsGrp/TotalAmt011730
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/ContriRptFundraisingEventAmt019905
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01547145
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt01
IRS990/CYOtherExpensesAmt01054058
IRS990/CYOtherRevenueAmt0468291
IRS990/CYProgramServiceRevenueAmt0121761
IRS990/CYRevenuesLessExpensesAmt0722629
IRS990/CYSalariesCompEmpBnftPaidAmt0360511
IRS990/CYTotalExpensesAmt01414569
IRS990/CYTotalFundraisingExpenseAmt080096
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02137198
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt048223
IRS990/DepreciationDepletionGrp/TotalAmt048223
IRS990/Desc0ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0true
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt05
IRS990/EmploymentTaxReturnsFiledInd0false
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0227956
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt012835
IRS990/FeesForServicesAccountingGrp/TotalAmt012835
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt02972
IRS990/FeesForServicesLegalGrp/TotalAmt02972
IRS990/FeesForServicesManagementGrp/ManagementAndGeneralAmt0398000
IRS990/FeesForServicesManagementGrp/TotalAmt0398000
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt013130
IRS990/FeesForServicesOtherGrp/TotalAmt013130
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt010.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt20.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.75
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt121.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/PersonNm0JAMES R BERENSON MD
IRS990/Form990PartVIISectionAGrp/PersonNm1GEO HARTLEY ESQ
IRS990/Form990PartVIISectionAGrp/PersonNm2SHAHROOZ ESHAGHIAN MD
IRS990/Form990PartVIISectionAGrp/PersonNm3CYNDIE DUNLAP
IRS990/Form990PartVIISectionAGrp/PersonNm4ROGER FISCHER
IRS990/Form990PartVIISectionAGrp/PersonNm5RICHARD GARDINER MD
IRS990/Form990PartVIISectionAGrp/PersonNm6RICHARD KALE ESQ
IRS990/Form990PartVIISectionAGrp/PersonNm7BLAKE MORRISON PHARMD
IRS990/Form990PartVIISectionAGrp/PersonNm8KELLEY NICHOLS
IRS990/Form990PartVIISectionAGrp/PersonNm9MICHAEL SCHIFF ESQ
IRS990/Form990PartVIISectionAGrp/PersonNm10LARRY STEIN ESQ
IRS990/Form990PartVIISectionAGrp/PersonNm11MERRYL WERBER
IRS990/Form990PartVIISectionAGrp/PersonNm12JESSICA YATACO
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT AN
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE PRESIDE
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12TREASURER
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0true
IRS990/FundraisingAmt019905
IRS990/FundraisingGrossIncomeAmt083299
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt012
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt02137198
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt012
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt035507
IRS990/InsuranceGrp/TotalAmt035507
IRS990/InterestGrp/ProgramServicesAmt0132163
IRS990/InterestGrp/TotalAmt0132163
IRS990/InventoriesForSaleOrUseGrp/BOYAmt0570273
IRS990/InventoriesForSaleOrUseGrp/EOYAmt0761385
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt01
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt01
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/BOYAmt0451
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt0451
IRS990/IRPDocumentCnt07
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0330250
IRS990/LandBldgEquipBasisNetGrp/BOYAmt029275
IRS990/LandBldgEquipBasisNetGrp/EOYAmt049779
IRS990/LandBldgEquipCostOrOtherBssAmt0380029
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt02750073
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt02878184
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FORM 990 PART III LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH IN TO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES. THE INSTITUTE'S TWO MAJOR ACTIVITIES WILL BE (1) RESEARCH RELATED TO THE CAUSES OF MYELOMA AND RELATED DISORDERS AND (2) DEVELOPMENT OF THERAPIES TO PREVENT AND TREAT MYELOMA AND RELATED DISORDERS.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0-2284772
IRS990/NetAssetsOrFundBalancesEOYAmt0-1562143
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt083299
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ManagementAndGeneralAmt0138658
IRS990/OccupancyGrp/TotalAmt0138658
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt010442
IRS990/OfficeExpensesGrp/TotalAmt010442
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt014513
IRS990/OtherAssetsTotalGrp/EOYAmt0228806
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt09209
IRS990/OtherEmployeeBenefitsGrp/TotalAmt09209
IRS990/OtherExpensesGrp/Desc0OTHER EXPENSES
IRS990/OtherExpensesGrp/Desc1LABORATORY EXPENSES
IRS990/OtherExpensesGrp/Desc2COGS
IRS990/OtherExpensesGrp/Desc3OUTSIDE SERVICES
IRS990/OtherExpensesGrp/FundraisingAmt030528
IRS990/OtherExpensesGrp/FundraisingAmt11966
IRS990/OtherExpensesGrp/ProgramServicesAmt051014
IRS990/OtherExpensesGrp/ProgramServicesAmt138114
IRS990/OtherExpensesGrp/ProgramServicesAmt215488
IRS990/OtherExpensesGrp/TotalAmt051014
IRS990/OtherExpensesGrp/TotalAmt138114
IRS990/OtherExpensesGrp/TotalAmt230528
IRS990/OtherExpensesGrp/TotalAmt317454
IRS990/OtherLiabilitiesGrp/BOYAmt0262919
IRS990/OtherLiabilitiesGrp/EOYAmt0112353
IRS990/OtherRevenueMiscGrp/Desc0RESTRICTED FUNDS
IRS990/OtherRevenueMiscGrp/Desc1OTHER INCOME
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt0325000
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt159672
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt0325000
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt159672
IRS990/OtherRevenueTotalAmt0384672
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0312133
IRS990/OtherSalariesAndWagesGrp/TotalAmt0312133
IRS990/PartialLiquidationInd0false
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt027134
IRS990/PayrollTaxesGrp/TotalAmt027134
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt012035
IRS990/PensionPlanContributionsGrp/TotalAmt012035
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt05000
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0157708
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt049621
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt059135
IRS990/PrincipalOfficerNm0JAMES R BERENSON MD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/BusinessCd0541700
IRS990/ProgramServiceRevenueGrp/BusinessCd1541700
IRS990/ProgramServiceRevenueGrp/Desc0SERVICE INCOME - BLOOD
IRS990/ProgramServiceRevenueGrp/Desc1RESEARCH SERVICE REVENUE
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt072697
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt149064
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt072697
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt149064
IRS990/ProgSrvcAccomActyOtherGrp/Desc0ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt0100168
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt0833907
IRS990/PYExcessBenefitTransInd0false
IRS990/PYOtherExpensesAmt01006070
IRS990/PYOtherRevenueAmt063679
IRS990/PYProgramServiceRevenueAmt0248425
IRS990/PYRevenuesLessExpensesAmt0-147085
IRS990/PYSalariesCompEmpBnftPaidAmt0287026
IRS990/PYTotalExpensesAmt01293096
IRS990/PYTotalRevenueAmt01146011
IRS990/ReconcilationRevenueExpnssAmt0722629
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0true
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0true
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RoyaltiesRevenueGrp/ExclusionAmt0320
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt0320
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt0-2284772
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt0-1562143
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01547145
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0833907
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01768880
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01642232
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt02220102
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt08012266
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0320
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0269
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0394
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0462
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0242
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt01687
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt02329209
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.92150
IRS990ScheduleA/PublicSupportPY170Pct00.97560
IRS990ScheduleA/PublicSupportTotal170Amt07384603
IRS990ScheduleA/SubstantialContributorsTotAmt0627663
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01547145
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0833907
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01768880
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01642232
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt02220102
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt08012266
IRS990ScheduleA/TotalSupportAmt08013953
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/EndowmentsHeldRelatedOrgInd0false
IRS990ScheduleD/EndowmentsHeldUnrelatedOrgInd0false
IRS990ScheduleD/ExpensesSubtotalAmt01414569
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt0130878
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt197928
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0DUE FROM JRB MD INC
IRS990ScheduleD/OtherAssetsOrgGrp/Desc1PATENTS PENDING
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt049779
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt0330250
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt0380029
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt070954
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt120523
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt29703
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt37273
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt43900
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0LEASES & NOTES PAYABLE
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1SALARY PAYABLE
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc2SHORT TERM NOTES
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc3ACCRUED EXPENSES
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc4UNEARNED FUNDRAISING REVENUE
IRS990ScheduleD/RevenueSubtotalAmt02137198
IRS990ScheduleD/TotalBookValueLandBuildingsAmt049779
IRS990ScheduleD/TotalBookValueOtherAssetsAmt0228806
IRS990ScheduleD/TotalExpensesPerForm990Amt01414569
IRS990ScheduleD/TotalLiabilityAmt0112353
IRS990ScheduleD/TotalRevenuePerForm990Amt02137198
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt02137198
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt01414569
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContributionsTotAmt019905
IRS990ScheduleG/FundraisingEventInformationGrp/CharitableContriEvent1Amt019905
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm0EVENTS INCOME
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent1Amt0103204
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsTotalAmt0103204
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent1Amt083299
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueTotalEventsAmt083299
IRS990ScheduleG/FundraisingEventInformationGrp/NetIncomeSummaryAmt083299
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt02878184
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt02055688
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0JAMES R BERENSON
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0PRESIDENT
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0false
IRS990ScheduleL/SupplementalInformationDetail/ExplanationTxt0SCHEDULE L, PART II, LOANS TO AND FROM INTERESTED PERSONS: (A) NAME OF PERSON: JAMES R. BERENSON, MD INC (B) RELATIONSHIP WITH ORGANIZATION: OWNED BY DIRECTOR (A) NAME OF PERSON: ONCOTHERAPEUTICS, INC (B) RELATIONSHIP WITH ORGANIZATION: OWNED BY DIRECTOR (A) NAME OF PERSON: ONCOTRACKER, INC (B) RELATIONSHIP WITH ORGANIZATION: OWNED BY DIRECTOR (A) NAME OF PERSON: JAMES R. BERENSON (B) RELATIONSHIP WITH ORGANIZATION: PRESIDENT
IRS990ScheduleL/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE L, PART V
IRS990ScheduleL/TotalBalanceDueAmt02878184
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FORM 990 PART III LINE 1 THE INSTITUTE FOR MYELOMA AND BONE CANCER RESERACH IS ESTABLISHED FOR THE FOLLOWING PURPOSES: (I) TO PROMOTE RESEARCH IN TO THE CAUSES OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, (II)TO SUPPORT THE DEVELOPMENT OF THERAPIES DESIGNED TO TREAT AND CONTROL MYELOMA, BONE CANCER, AND RELATED DISORDERS, AND (III) TO ADVANCE EFFORTS DIRECTED AT PREVENTING THE DEVELOPMENT OF MYELOMA, BONE CANCER, AND RELATED DISORDERS, INCLUDING THE TREATMENT OF PERSONS HAVING SUCH DISEASES. THE INSTITUTE'S TWO MAJOR ACTIVITIES WILL BE (1) RESEARCH RELATED TO THE CAUSES OF MYELOMA AND RELATED DISORDERS AND (2) DEVELOPMENT OF THERAPIES TO PREVENT AND TREAT MYELOMA AND RELATED DISORDERS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1IMBCR STARTED MARKETING AND SELLING SMALL AMOUNTS OF BLOOD AND BONE MARROW SAMPLES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2ACHIEVED ADVANCEMENTS IN THE RESEARCH AND CURE FOR MYELOMA. RESEARCH HAS HELPED CURE OR REDUCE THE OCCURRENCE OF MYELOMA IN HUMANS.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.